Cambium Biomaterials Inc.
El Segundo, CA
- UEI
- K9VZECDZ2YN9
- CAGE
- 8FWV3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Mooresville, NC HSHAD523R5G3
-
- SAM.gov registration date
- Physical address
- 111 Maryland St, El Segundo, CA 90245, USA
- Website
- cambium-usa.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Capital Goods
- Aerospace & Defense
- SIC code
- 37 Transportation Equipment
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $4,699,750 |
| FY2025 | $9,235,062 |
| FY2024 | $9,148,072 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Navy | $4,699,750 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Booz Allen Hamilton Inc. | FA807524F0020 | $6,508,668 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $9,510,449 | |
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $624,830 | |
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $198,854 |
Similar vendors
About the company
Cambium Biomaterials Inc., headquartered in El Segundo, California, develops advanced biomaterials, high-performance composites, and fire-resistant and laser-protective systems for the Department of Defense as a prime contractor (64% of recent awards) and as a subcontractor on Army ground vehicle systems research. The company is a for-profit corporate entity without SBA set-aside designations; it competes full-and-open across its defense customer base. Cambium holds a named subsidiary, SHD Composite Materials Inc., a manufacturer of goods.
Cambium's customer concentration is entirely defense-focused and heavily weighted to the Navy. The Office of Naval Research funds five awards carrying $23.1 million in combined potential value — 97% of Cambium's total pipeline value and spanning phthalonitrile-based foam materials for fire protection on naval vessels ($4.7 million definitive contract awarded June 2026, completion August 2027), advanced biomaterial-based laser protection systems for optical sensor packages ($9.2 million OTA awarded September 2025, completion September 2027), biomaterial-based laser protective eyewear for warfighters ($4.4 million OTA awarded September 2024, completion November 2025), and thermal protection systems for hypersonic missiles ($4.7 million definitive contract awarded September 2024, completed September 2025). The Naval Air Warfare Center placed one sole-source award ($348 thousand, completed December 2022) for biosynthetic composite material fabrication and testing. The Defense Advanced Research Projects Agency holds one OTA IDV ($399 thousand ceiling, awarded August 2025) focused on titanium replacement in military systems through artificial intelligence. The Army, via Booz Allen Hamilton, engages Cambium as a subcontractor on ground vehicle systems technology and laboratory research and development work.
Cambium also holds four federal grant sub-awards as a sub-recipient under the Bioindustrial Manufacturing and Design Ecosystem (BIMADE) prime grantee, spanning domestic biological production of novel polymers for directed energy applications and detailed research projects awarded in 2021, 2022, and 2023. Activity has been episodic — two awards in 2022, declining to one in 2023, rising to three each in 2024 and 2025, with one award in 2026 — generating $23.8 million in combined potential value but $40.7 million in obligated dollars, indicating accelerated spend-down. Two awards (combined potential value $13.9 million) reach ultimate completion within the next twenty-four months, creating recompete exposure. NAICS concentration sits with Research and Development in the Physical, Engineering, and Life Sciences (five awards), with PSC work split between Department of Defense military experimental development and applied research classifications. Cambium's capability portfolio centers on thermal and optical protective materials, resin synthesis, carbon fiber composite fabrication, and ablative systems engineering — all engineered for naval vessels, hypersonic platforms, and warfighter equipment.
Quick answers
Is Cambium Biomaterials Inc. registered in SAM.gov?
Yes. Cambium Biomaterials Inc.'s SAM.gov registration is active through February 10, 2027.
What is Cambium Biomaterials Inc.'s CAGE code?
Cambium Biomaterials Inc.'s CAGE code is 8FWV3, and its Unique Entity ID (UEI) is K9VZECDZ2YN9.
How much has Cambium Biomaterials Inc. received in federal contracts?
Federal contracts obligated $9,235,062 to Cambium Biomaterials Inc. in fiscal year 2025 and $23,082,884 in fiscal years 2023 through 2027.
How does Cambium Biomaterials Inc. rank among federal contractors?
Cambium Biomaterials Inc. ranked #22 in PSC 8030 and #62 in PSC 80 in FY2025.
What is Cambium Biomaterials Inc.'s most recent federal award?
Cambium Biomaterials Inc.'s most recent federal contract award is Cambium will advance and demonstrate phthalonitrile-based (PN) foam materials to enhance fire protection aboard U.S… (N0001426C1302), from Office of Naval Research (SECNAV), on June 15, 2026.
On GovTribe
See Cambium Biomaterials Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors